PREDICTIVE VALUE OF PATIENT-REPORTED OUTCOMES TO MUCOSAL HEALING IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引:0
|
作者
Colombel, J. F. [1 ]
Han, C. [2 ]
Reinisch, W. [3 ]
Feagan, B. [4 ]
Marano, C. [5 ]
Strauss, R. [5 ]
Johanns, J. [5 ]
Zhang, H. [5 ]
Gibson, P. [6 ]
Collins, J. [7 ]
Rutgeerts, P. [8 ]
Sandborn, W. [9 ]
机构
[1] Ctr Hosp Univ Lille, Lille, France
[2] Janssen Global Serv LLC, Malvern, PA USA
[3] Univ Vienna, Vienna, Austria
[4] Univ Western Ontario, Robarts Res Inst, London, ON, Canada
[5] Janssen R&D LLC, Spring House, PA USA
[6] Alfred Hosp, Melbourne, Vic, Australia
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[8] Univ Hosp Gasthuisberg, Leuven, Belgium
[9] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.jval.2014.03.239
中图分类号
F [经济];
学科分类号
02 ;
摘要
PGI27
引用
收藏
页码:A40 / A40
页数:1
相关论文
共 50 条
  • [31] Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study
    Golovics, Petra Anna
    Gonczi, Lorant
    Reinglas, Jason
    Verdon, Christine
    Pundir, Sheetal
    Afif, Waqqas
    Wild, Gary
    Bitton, Alain
    Bessissow, Talat
    Lakatos, Peter L.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3089 - 3095
  • [32] Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study
    Petra Anna Golovics
    Lorant Gonczi
    Jason Reinglas
    Christine Verdon
    Sheetal Pundir
    Waqqas Afif
    Gary Wild
    Alain Bitton
    Talat Bessissow
    Peter L. Lakatos
    Digestive Diseases and Sciences, 2022, 67 : 3089 - 3095
  • [33] Cost per clinical outcomes with biologics for the treatment of moderately to severely active ulcerative colitis
    Jansen, J.
    Mody, R.
    Ursan, I.
    Lorenzi, M.
    Patel, H.
    Alberton, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S239 - S240
  • [34] Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
    Sandborn, W. J.
    Schreiber, S.
    Lee, S. D.
    Lindsay, J. O.
    Hebuterne, X.
    Zhou, W.
    Cataldi, F.
    Lacerda, A. P.
    Huang, B.
    Xie, W.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S9 - S9
  • [35] Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
    Panes, Julian
    Su, Chinyu
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Mamolo, Carla
    Healey, Paul
    BMC GASTROENTEROLOGY, 2015, 15
  • [36] Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
    Julián Panés
    Chinyu Su
    Andrew G Bushmakin
    Joseph C Cappelleri
    Carla Mamolo
    Paul Healey
    BMC Gastroenterology, 15
  • [37] Improvement in fatigue with mirikizumab therapy is associated with improvements in patient-reported outcomes in patients with moderately to severely active Crohn's disease
    Reguiero, Miguel
    Fischer, Monika
    Rubin, David T.
    Hibi, Toshifumi
    Bossuyt, Peter
    Juillerat, Pascal
    Pollack, Paul
    Zhou, Xian
    Protic, Marijana
    Hunter, Theresa
    Chan, Lai Shan
    Carlier, Hilde
    Hindryckx, Pieter
    SWISS MEDICAL WEEKLY, 2023, 153 : 26S - 27S
  • [38] The Impact of Adalimumab vs Placebo on Patient-Reported Outcomes and Utility Measures Among Patients with Moderately to Severely Active Psoriatic Arthritis
    Strand, Vibeke
    Patel, Pankaj
    Chen, Naijun
    Lesser, Elizabeth M.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] THE IMPACT OF ADALIMUMAB VS PLACEBO ON PATIENT-REPORTED OUTCOMES AND UTILITY MEASURES AMONG PATIENTS WITH MODERATELY TO SEVERELY ACTIVE PSORIATIC ARTHRITIS
    Strand, V.
    Patel, P.
    Chen, N.
    Lesser, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1718 - 1719
  • [40] The predictive factor for relapse of ulcerative colitis in patients with endoscopic mucosal healing
    Yamakawa, K.
    Yoshino, T.
    Nishimura, S.
    Watanabe, K.
    Yazumi, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S61 - S61